Rechercher des projets européens

Plus de 40 projets européens trouvés

Recherche sur 125080 projets européens

 TERMINÉ 

Integrated next-generation flow cytometry and sequencing to uncover the pathway of curability in multiple myeloma (MYELOMANEXT)

Date du début: 1 sept. 2016, Date de fin: 31 août 2021,

Multiple myeloma (MM) represents a unique model to investigate cancer stem cells (CSCs), circulating tumour cells (CTCs), and the mechanisms of malignant transformation and chemoresistance. Despite the substantial improvement in MM patients’ outcome, the vast majority of patients eventually relapse and the disease remains largely incurable. For those patients failing to achieve deep remissions, bi ...
Voir le projet

 2

 TERMINÉ 

REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy (RESPINE)

Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,

The World Health Organisation (WHO) has included low back pain in its list of twelve priority diseases. Notably, Degenerative disc disease (DDD) presents a large, unmet medical need which results in a disabling loss of mechanical function. Today, no efficient therapy is available. Chronic cases often receive surgery, which may lead to biomechanical problems and accelerated degeneration of adjacent ...
Voir le projet

 18

 TERMINÉ 

SmArt BI-directional multi eNergy gAteway (SABINA)

Date du début: 1 nov. 2016, Date de fin: 31 oct. 2020,

...l inertia in buildings and the coupling between heat and electricity networks it enables.This coupling requires accurately estimating the thermal inertia of many buildings. SABINA’s partner the University of Navarra has created a breakthrough, automatic method for this estimation, which shall be scaled up, validated and integrated in a complete management system through this project. This system w ...
Voir le projet

 10

 TERMINÉ 

Professional cross-priming for ovary and prostate cancer (PROCROP)

Date du début: 1 sept. 2015, Date de fin: 31 août 2020,

Immune responses are initiated by antigen presentation mediated by dendritic cells (DC). There is a minority subset of DC highly specialised in starting up cytotoxic T lymphocytes able to kill tumor cells. PROCROP aims to develop in three pilot clinical trials a suitable individualized cancer vaccine technology for castration resistant prostate cancer and metastatic cancer of the ovary that would ...
Voir le projet

 8

 TERMINÉ 

GrowSmarter

Date du début: 1 janv. 2015, Date de fin: 31 déc. 2019,

GrowSmarter aims to:• Improve the quality of life for European citizens by better mobility, housing and the quality of urban infrastructure while improving the citizens economy by lower energy costs and creating as much as 1500 new jobs (on the demonstration level).• Reduce the environmental impact by lower energy needs by 60 % and increased use of renewable energy thus reducing GHG emissions eve ...
Voir le projet

 41

 TERMINÉ 

Innovative multi-functional Vacuum-Insulation-Panels (VIPs) for use in the building sector (INNOVIP)

Date du début: 1 oct. 2016, Date de fin: 30 sept. 2019,

INNOVIP Consortium will reinvent the top-of-the-line insulating material vacuum-insulation-panels (VIP) by improving their thermal performance over the entire lifetime by at least 25 % and making VIPs adjustable, mountable and machineable. By reducing the density of the core material and/or using an alternative core material together with less expensive VIP-envelopes as gas barrier, it will be po ...
Voir le projet

 13

 TERMINÉ 

Low Cost Materials Processing Technologies for Mass Production of Lightweight Vehicles (LoCoMaTech)

Date du début: 1 sept. 2016, Date de fin: 31 août 2019,

The overall aim of LoCoMaTech is, in the first place, to enable the novel HFQ® process, (patented by ICL) in its latest most advanced form, which includes 10 recently patented refining technologies (TRL4), to be used for the manufacture of lightweight, high strength body and chassis structures and components for low-cost vehicles, by establishing a prototype, full scale pilot production line (TRL6 ...
Voir le projet

 20

 TERMINÉ 

PAn-European Clusters for Technology Transfer and new VAlue chains (ACTTiVAte)

Date du début: 1 juin 2016, Date de fin: 31 mai 2019,

The overall concept of the project consist of supporting innovation in SMEs and fostering the smart reindustrialization of Europe by enabling the emergence of new cross-border and cross-sectoral value chains resulting from the translation of advanced technologies among selected sectors with strong synergies. These new value chains will be created from the interaction of the following sectors: aer ...
Voir le projet

 13

 TERMINÉ 

Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication. (INPACT)

Date du début: 1 févr. 2015, Date de fin: 31 janv. 2019,

...a, Spain), a consolidated media partner specialised in science communication (Ciencia Hoje, Rio de Janeiro, Brazil) and experts in international science funding from one of the top US universities (University of Stanford). The consortium will be the perfect environment for young researchers to acquire knowledge and skills in science, technology, entrepreneurship, business, and communication so the ...
Voir le projet

 8

 TERMINÉ 

PREVention of diabetes through lifestyle Intervention and population studies in Europe and around the World (PREVIEW)

Date du début: 1 janv. 2013, Date de fin: 31 déc. 2018,

"The primary goal of PREVIEW is to identify the most efficient lifestyle pattern for the prevention of type-2 diabetes in a population of pre-diabetic overweight or obese individuals. The project comprises two distinct lines of evidence, both embracing European and overseas countries:1) A multicentre, clinical randomized intervention trial with a total of 2,500 pre-diabetic participants, including ...
Voir le projet

 16

 TERMINÉ 

I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly (I-MOVE-plus)

Date du début: 1 mai 2015, Date de fin: 31 oct. 2018,

The I-MOVE+ Consortium includes European Union (EU) Public Health Institutes, SME and Universities. It aims at measuring and comparing the effectiveness (VE) and impact (VI) of influenza and Pneumococcal vaccines and vaccination strategies a in the elderly population in Europe. The goal is to develop a sustainable platform of primary care practices, hospitals and laboratory networks that share val ...
Voir le projet

 33

 TERMINÉ 

The MEDiterranean Public HEALTH Alliance (MED-HEALTH)

Date du début: 15 oct. 2015, Date de fin: 14 oct. 2018,

A solid public health system constitutes a pillar of advanced societies, capable of providing their citizens with an enabling environment for development and smart and inclusive societies. All countries in Europe and beyond need to address increasingly global health challenges with the support of innovative approaches and skilled professionals. To do so, HEIs need to introduce programmes with a wi ...
Voir le projet

 13

 TERMINÉ 

History of Nuclear Energy and Society (HoNESt)

Date du début: 1 sept. 2015, Date de fin: 31 août 2018,

HoNESt (History of Nuclear Energy and Society) involves an interdisciplinary team with many experienced researchers and 24 high profile research institutions.HoNESt’s goal is to conduct a three-year interdisciplinary analysis of the experience of nuclear developments and its relationship to contemporary society with the aim of improving the understanding of the dynamics over the last 60 years. HoN ...
Voir le projet

 26

 TERMINÉ 

Cancer Vaccine development for Hepatocellular Carcinoma (HepaVac)

Date du début: 1 sept. 2013, Date de fin: 31 août 2018,

"Hepatocellular carcinoma (HCC) is the most common primary liver cancer and accounts for about 6% of all new cancer cases worldwide. Given the lack of available effective treatments, the overall prognosis for HCC patients is poor, with a dismal 5-year survival of 5-6%. The main goal of this proposal is to develop a therapeutic cancer vaccine aiming at improving clinical outcome in early-stage HCC ...
Voir le projet

 10

 TERMINÉ 

Smart Mature Resilience (SMR)

Date du début: 1 juin 2015, Date de fin: 31 mai 2018,

Smart Mature Resilience (SMR) will develop and validate Resilience Management Guidelines, using three pilot projects covering different CI security sectors, as well as climate change and social dynamics. The Resilience Management Guidelines will provide a robust shield against man-made and natural hazards, enabling society to resist, absorb, accommodate to and recover from the effects of a hazard ...
Voir le projet

 14

 TERMINÉ 

Evaluating the impact of socialization tactics, social networks and demographic similarity on newcomers’ organizational socialization and performance in a longitudinal cross-industry data sample (SocialiseME)

Date du début: 1 avr. 2014, Date de fin: 31 mars 2018,

Organisational socialisation, or how we “acquire the social knowledge and skills necessary to assume an organisational role”, is now more relevant than ever due to current socio-economic trends that have repercussions on individuals, organisations and the overall society. The 2008 Great Recession put the cost-structures of EU organisations under great stress, and failure in newcomer socialisation ...
Voir le projet

 2

 TERMINÉ 

Indium-Free Transparent Conductive Oxides for Glass and Plastic Substrates (INFINITY)

Date du début: 1 déc. 2014, Date de fin: 31 janv. 2018,

INFINITY will develop an inorganic alternative to a scarce and high cost material, indium tin oxide (ITO), currently used as a Transparent Conductive Coating (TCC) for display electrodes on glass and plastic substrates. The novel conductive materials to be developed in this project will be based on low cost sol-gel chemistry using more widely available metallic elements and will leverage recent ad ...
Voir le projet

 9

 TERMINÉ 

European ICT Sector Skills Alliance - VET open course for mobile apps creators

Date du début: 1 janv. 2015, Date de fin: 31 déc. 2017,

A. REASON FOR THE APPSKIL PROJECTAppSkil aims to form an ICT Sector Skills Alliance focused on the mobile apps field that will: a) act as a collaboration platform that will link VET providers, sector representatives, and VET authorities, b) identify skills needs & mismatches, and c) develop and deliver an appropriate training programme connected with qualification frameworks. AppSkil faces the cha ...
Voir le projet

 14

 TERMINÉ 

Bioactivated hierarchical hydrogels as zonal implants for articular cartilage regeneration (HYDROZONES)

Date du début: 1 janv. 2013, Date de fin: 31 déc. 2017,

Degeneration of cartilage is a major cause of chronic pain, lost mobility and reduced quality of life for millions of European citizens. From a clinical point of view treatment to achieve cartilage regeneration (hyaline) and not only repair (fibrous) remains a great challenge. No clinical therapy is available that leads to healing of cartilage defects.Current cartilage implants cannot establish th ...
Voir le projet

 18

 TERMINÉ 

Biological control manufacturers in Europe develop novel biological control products to support the implementation of Integrated Pest Management in agriculture and forestry (BIOCOMES)

Date du début: 1 déc. 2013, Date de fin: 30 nov. 2017,

"The objective of BIOCOMES is to develop 11 new biological control agents (BCAs) for key markets in European agriculture and forestry. BCAs were identified through market analysis by six manufactures of biological control products. BCAs will primarily be for use in open field crops of vegetables (3), of which 2 are also for use in protected crops, arable crops (3), fruit crops (3), and three diffe ...
Voir le projet

 27

 TERMINÉ 

Immunostimulatory Agonist antibodies for Cancer Therapy (IACT)

Date du début: 1 nov. 2013, Date de fin: 31 oct. 2017,

"This concerted action aims at providing new treatment options for cancer patients through boosting innovative drug development by European academia and industry. A wealth of preclinical data shows that the therapeutic impact of cytotoxic regimens is enhanced by simultaneous application of drugs that strengthen the immune system. The recent FDA-approval of Ipilimumab demonstrated that cancer immun ...
Voir le projet

 11

 TERMINÉ 

LEACHE – Europa más cerca

Date du début: 1 juin 2015, Date de fin: 31 mai 2017,

The Department for Education of the Government of Navarra is responsible for establishing the general conditions and developing general aspects of education in this Spanish autonomous region. In this context, a new structure has been created in the Vocational Training Service in order to provide assistance for the internationalization of VET institutions. These measures try to reach the following ...
Voir le projet

 91

 TERMINÉ 

A FAST process and production system for high-throughput, highly flexible and cost-efficient volume production of miniaturised components made of a wide range of materials (Micro-FAST)

Date du début: 1 sept. 2013, Date de fin: 28 févr. 2017,

The aim of the project is to develop a completely new manufacturing system for the volume production of miniaturised components by overcoming the challenges on the manufacturing with a wide range of materials (metallic alloys, composites, ceramics and polymers), through: (i) developing a high-throughput, flexible and cost-efficient process by simultaneous electrical-forming and electric-fast-sinte ...
Voir le projet

 17

 TERMINÉ 

RADical reduction of OXidative stress in cardiovascular diseases (RADOX)

Date du début: 1 janv. 2013, Date de fin: 31 déc. 2016,

Cardiovascular disease (CVD) constitutes a major and increasing health burden in developed countries. The prediction is that the prevalence of these conditions will increase by ~60% over the next 20 years. Therefore, the development of novel treatments for patients with CVD becomes more and more urgent. Oxidative stress is an important molecular contributor to the pathogenesis of CVD. However, ox ...
Voir le projet

 10

 TERMINÉ 

INNOVACTIS 2015-2016

Date du début: 1 janv. 2015, Date de fin: 31 déc. 2016,

The objective of this project is to provide innovation support services in 2015 and 2016 to SMEs in the regions covered by the consortium members. These innovation support services will be differentiated for two groups of SMEs: a) SMEs that have been selected as beneficiaries of the SME instrument, phase 1 or phase 2. For these companies, the consortium members will offer Key Account Management (K ...
Voir le projet

 11

 TERMINÉ 

High Shear Processing of Recycled Aluminium Scrap for Manufacturing High Performance Aluminium Alloys (Recycal)

Date du début: 1 janv. 2014, Date de fin: 31 déc. 2016,

...h and continuous metal processing. It is based on leading edge research into the heterogeneous nucleation and growth in aluminium alloys, and its promotion by dispersed oxides.This research at Brunel University has demonstrated that the physical processing of liquid metals transforms oxides in melts from defects to active nuclei. This results in refined cast microstructures with significantly impr ...
Voir le projet

 13

 TERMINÉ 

An industry system enabling the use of a patented materials processing technology for Low Cost forming of Lightweight structures for transportation industries (LoCoLite)

Date du début: 1 déc. 2013, Date de fin: 30 nov. 2016,

... vehicles. Reduced pollution is a natural corollary of low energy consumption.Exploitation of this groundbreaking technology will be achieved through refinement of its laboratory scale development by university, research institution and manufacturing SME collaboration, leading to production lines being established in Tier 1 companies. Two such lines are anticipated as an outcome of the project. In ...
Voir le projet

 16

 TERMINÉ 

Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (AMD) (TARGETAMD)

Date du début: 1 nov. 2012, Date de fin: 31 oct. 2016,

Age-related Macular Degeneration (AMD), a neurodegenerative disease of the retina, is a major cause of blindness in elderly people. Due to the aging population, AMD has been referred to as a “time bomb” in society. In the exudative form of AMD, high levels of vascular endothelial cell growth factor (VEGF) and low levels of pigment-epithelial derived factor (PEDF), an inhibitor of vascularization a ...
Voir le projet

 16

 TERMINÉ 

Patient-centered palliative care pathways in advanced cancer and chronic disease (INSUP-C)

Date du début: 1 nov. 2012, Date de fin: 31 oct. 2016,

Integrated delivery systems of care, e.g. networks of health organizations and professionals who work together to coordinate services to meet their patients’ needs, are an important way of linking fragmented services and maximizing system efficiency and seamlessness of patient transition. Research increasingly shows that patients with advanced cancer and advanced chronic disease are treated well ...
Voir le projet

 11

 TERMINÉ 

Trade Preferences as Development Aid: Theory and Evidence (Trade as Aid)

Date du début: 1 sept. 2012, Date de fin: 31 août 2016,

Over the last 10 years the use of Special Trade Preferences – the granting of lower import tariffs to specific countries – has increasingly been used as a tool to encourage development in developing countries, primarily in Africa. Yet, despite the popularity of these tools - practically all sub-Saharan countries receive some form of special trade preferences - we have little understanding of how w ...
Voir le projet

 2

 TERMINÉ 

Drug Disease Model Resources (DDMORE)

Date du début: 1 mars 2011, Date de fin: 31 août 2016,

Model based-drug development (MBDD) is accepted as a vital approach in understanding patient risk/benefit and attrition. At the core of MBDD lies Modelling and Simulation (M&S), a technology providing the basis for informed, quantitative decision-making.M&S facilitates the continuous integration of available information related to a drug or disease into constantly-evolving mathematical models capa ...
Voir le projet

 28

 TERMINÉ 

Mucus Permeating Nanoparticulate Drug Delivery Systems (ALEXANDER)

Date du début: 1 avr. 2012, Date de fin: 31 mars 2016,

The objective of the ALEXANDER project is the identification of novel strategies (e.g., proteolytic enzyme strategy, thiomer strategy, zeta potential changing systems, SNEDDS strategy) and the optimization of existing strategies (e.g., disulfide breaking strategy and slippery surface strategy) for the efficient transport of nanocarriers through the mucus gel layer (e.g., intestinal, nasal, ocular, ...
Voir le projet

 20

 TERMINÉ 

Development of NEXT GENeration cost efficient automotive CATalysts (NEXT-GEN-CAT)

Date du début: 1 févr. 2012, Date de fin: 31 janv. 2016,

The main objective of NEXTGENCAT proposal is the development of novel eco-friendly nano-structured automotive catalysts utilizing transition metal nanoparticles (Cu, Ni, Co Zn, Fe etc) that can partially or completely replace the PGMs. Based on nanotechnology, low cost nanoparticles will be incorporated into different substrates, including advanced ceramics (SiO2, perovskite etc) and silicon carbi ...
Voir le projet

 11

 TERMINÉ 

EPIC-CVD: Individualised CVD risk assessment: tailoring targeted and cost-effective approaches to Europe's diverse populations (EPIC-CVD)

Date du début: 1 janv. 2012, Date de fin: 31 déc. 2015,

"EPIC-CVD's overarching goal is to provide clinicians and policy-makers with a menu of evidence-based options for cost-effective individualised risk assessment that enables the EU's increasingly resource-constrained economies to achieve more personalised predictive medicine in harmony with Europe's diverse cultures and healthcare systems.We will achieve this through developing and validating innov ...
Voir le projet

 33

 TERMINÉ 

Targeted delivery for liver cancer treatment (HEPTAG EXCHANGE)

Date du début: 1 janv. 2012, Date de fin: 31 déc. 2015,

The Liver cancer drugs market is expected to become an active ground for competition in the future. According to recent market analysis, the liver cancer market in 2009 was valued at approximately US$0.4bn, indicating a growth rate of 27.1% between 2001 and 2009. It is estimated that the liver cancer market in 2017 will be $1.2bn, with a compound annual growth rate (CAGR) of 15.5% between 2009 an ...
Voir le projet

 3

 TERMINÉ 

"Self-care Support for People with Long Term Conditions, Diabetes and Heart Disease: A Whole System Approach" (EU-WISE)

Date du début: 1 janv. 2012, Date de fin: 31 déc. 2015,

"The overall aim of this project is to offer a deeper understanding of the different mechanisms involved in the management of chronic conditions with a specific focus on how initiatives are translated and embedded into the illness management practices in peoples’ everyday life. It is in work, domestic and community settings where these practices are shaped by the emotional, symbolic, ethical, eco ...
Voir le projet

 10

 TERMINÉ 

Adopting Hospital Based Health Technology Assessment in EU (AdHopHTA)

Date du début: 1 sept. 2012, Date de fin: 30 nov. 2015,

The use of HTA as a part of the decision-making process at national, regional, and international levels has evolved considerably over the past 35 years. However, still an important number of good-value innovative HTs never reach clinical practice while, in many instances, others with no significant added value actually do. This situation can be effectively overcome by approaching HTA at hospital l ...
Voir le projet

 11

 TERMINÉ 

Cloud platforms Lead to Open and Universal access for people with Disabilities and for All (CLOUD4all)

Date du début: 1 nov. 2011, Date de fin: 31 oct. 2015,

As we move inextricably into a digital economy there is a looming crisis for a growing number of increasingly marginalized individuals. The accessibility technologies we have are meeting the needs of only some, at high cost, and will not work with many new technologies. The path and pace of technological change predestines these approaches to fail in the very near future. At the same time the inci ...
Voir le projet

 30

 TERMINÉ 

Building Sustainable Research capacity for Health and its Social Determinants in Low- and Middle-Income Countries (SDH-Net)

Date du début: 1 oct. 2011, Date de fin: 30 sept. 2015,

...om Mexico, Colombia, Brazil and South Africa, Tanzania, and Kenya. The team is complemented by three distinguished European institutions: London School of Hygiene and Tropical Medicine; COHRED, and University of Geneva. SDH-Net is coordinated by GIZ with long term experience in health research and capacity building in LMIC, and IESE Business School, excellent in management capacity building.SDH-Ne ...
Voir le projet

 11

 TERMINÉ 

Innovative strategies, methods and tools for occupational risks management of manufactured nanomaterials (MNMs) in the construction industry (SCAFFOLD)

Date du début: 1 mai 2012, Date de fin: 30 avr. 2015,

Manufacturated nanomaterials and nanocomposites are being considered for various uses in the construction industry and related infrastructure industries, not only for enhancing material properties and functions but also in the context of energy conservation. Despite the current relatively high cost of nano-enabled products, their use in construction materials is likely to increase because of highl ...
Voir le projet

 14